50% off Premium Yearly
Agilent TechnologiesACOMMENTMay 27, 2026Stock price when the opinion was issued
As of Jun 12, 2026. Market Open.
Is up 55% from its April lows. They just reported a strong quarter with 7% organic growth. The business is turning around, helped by re-shoring in life sciences, plus the rise of some medicine that require more hardware to produce. The FDA is less disruptive as expected. The life sciences sector looks attractive.
They report today. Last quarter was a bad miss. They need to tell a good story about pharma.